SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer

Autor: Emeric Boisteau, Eric François, Thomas Aparicio, Karine Le Malicot, Rabia Boulahssass, Thierry Lecomte, Pierre Laurent-Puig, Boris Guiu, Elena Paillaud, Marie-Pierre Galais, Daniel Lopez-Trabada Ataz, David Tougeron, Louis-Marie Dourthe, Rosine Guimbaud, Emmanuelle Samalin, Marie Moreau, Christophe Louvet, Côme Lepage, Astrid Lièvre

Publikováno v: Digestive and Liver Disease
Digestive and Liver Disease, 2022, 54 (6), pp.747-754. ⟨10.1016/j.dld.2022.03.001⟩

International audience; INTRODUCTION: Patients ≥ 70 years old constitute 40% of patients with advanced gastric cancer (GC). Ramucirumab plus Paclitaxel is a therapeutic option validated in the second-line treatment of advanced GC, but as older pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956b87763bce70cb767f65bf8004b4fa
https://pubmed.ncbi.nlm.nih.gov/35351371

MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer

Autor: Emeric Boisteau, Alexandra Lespagnol, Marie De Tayrac, Sébastien Corre, Anthony Perrot, Nathalie Rioux-Leclercq, Séverine Martin-Lannerée, Pascal Artru, Philippe Chalabreysse, Pierre-Guillaume Poureau, Laurent Doucet, Dahna Coupez, Jaafar Bennouna, Céline Bossard, Romain Coriat, Frédéric Beuvon, Lucile Bauguion, François Leclair, Romain Chautard, Thierry Lecomte, Serge Guyetant, Romain Desgrippes, Denis Grasset, Hélène Lhostis, Karine Bouhier-Leporrier, Frédéric Bibeau, Julien Edeline, Marie-Dominique Galibert, Astrid Lièvre

Publikováno v: Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2022, 46 (5), 11 p. ⟨10.1016/j.clinre.2022.101888⟩
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (5), 11 p. ⟨10.1016/j.clinre.2022.101888⟩

International audience; BACKGROUND: Low miR-31-3p expression was identified as predictive of anti-EGFR efficacy in RAS-wt mCRC. Primary tumor side was also proposed as a predictive factor of anti-EGFR benefit. This retrospective multicentric study ev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c33e4909cc0e8424f1c5f76afb5d98a
https://pubmed.ncbi.nlm.nih.gov/35189426

Improving the screening of precancerous anal lesions in high-risk subjects with normal cytology: A longitudinal cohort study using simple tests

Autor: Charlène Brochard, Laurent Siproudhis, Aurore Carlo, Claire Gouriou, Emeric Boisteau, Sébastien Henno, Johanna Moreau, Astrid Lièvre, Vincent Thibault, Annie Lion, Guillaume Bouguen

Publikováno v: Digestive and Liver Disease
Digestive and Liver Disease, 2020, 52 (11), pp.1359-1364. ⟨10.1016/j.dld.2020.08.022⟩
Digestive and Liver Disease, WB Saunders, 2020, 52 (11), pp.1359-1364. ⟨10.1016/j.dld.2020.08.022⟩

International audience; Unlabelled - For patients at high risk of anal cancer, annual screening strategies using invasive evaluation methods are stressful. According to a normal examination at baseline using simple and non invasive tests, the aim of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e13d8d8f4d1f36f4a71911bbad2a2fb
https://hal.science/hal-02959733